Overview

Clinical decision support studies how computer systems can help clinicians interpret patient records, identify risks, choose tests, and plan treatment. Approaches range from statistical and causal models to Bayesian reasoning, reinforcement learning, guideline rules and knowledge graphs, and language-model systems using retrieval or multiple agents; hybrid designs often use AI to extract information and deterministic logic to apply clinical rules. Systems are tested on electronic health records, guideline-based cases, medical images, and medication tasks, with growing use of reader studies and prospective workflow evaluations. A central challenge is that strong benchmark accuracy does not ensure safe performance with incomplete or shifting data, and systems must manage uncertainty, harmful errors, clinician oversight, and fit with real workflows.

Latest papers

244 papers27 papers in the last four weeks, up 42% on the four weeks before. 0.2% of all new papers.

Mar 15, 2026

Argumentation for Explainable and Globally Contestable Decision Support with LLMs

Large language models (LLMs) exhibit strong general capabilities, but their deployment in high-stakes domains is hindered by their opacity and unpredictability. Recent work has taken meaningful steps towards addressing these issues by augmenting LLMs with post-hoc reasoning based on computational argumentation, providing faithful explanations and enabling users to contest incorrect decisions. However, this paradigm is limited to pre-defined binary choices and only supports local contestation for specific instances, leaving the underlying decision logic unchanged and prone to repeated mistakes. In this paper, we introduce ArgEval, a framework that shifts from instance-specific reasoning to structured evaluation of general decision options. Rather than mining arguments solely for individual cases, ArgEval systematically maps task-specific decision spaces, builds corresponding option ontologies, and constructs general argumentation frameworks (AFs) for each option. These frameworks can then be instantiated to provide explainable recommendations for specific cases while still supporting global contestability through modification of the shared AFs. We investigate the effectiveness of ArgEval on treatment recommendation for glioblastoma, an aggressive brain tumour, and show that it can produce explainable guidance aligned with clinical practice.
Mar 11, 2026

abx_amr_simulator: A simulation environment for antibiotic prescribing policy optimization under antimicrobial resistance

Antimicrobial resistance (AMR) poses a global health threat, reducing the effectiveness of antibiotics and complicating clinical decision-making. To address this challenge, we introduce abx_amr_simulator, a Python-based simulation package designed to model antibiotic prescribing and AMR dynamics within a controlled, reinforcement learning (RL)-compatible environment. The simulator allows users to specify patient populations, antibiotic-specific AMR response curves, and reward functions that balance immedi- ate clinical benefit against long-term resistance management. Key features include a modular design for configuring patient attributes, antibiotic resistance dynamics modeled via a leaky-balloon abstraction, and tools to explore partial observability through noise, bias, and delay in observations. The package is compatible with the Gymnasium RL API, enabling users to train and test RL agents under diverse clinical scenarios. From an ML perspective, the package provides a configurable benchmark environment for sequential decision-making under uncertainty, including partial observability induced by noisy, biased, and delayed observations. By providing a customizable and extensible framework, abx_amr_simulator offers a valuable tool for studying AMR dynamics and optimizing antibiotic stewardship strategies under realistic uncertainty.
Mar 11, 2026

Depression Detection at the Point of Care: Automated Analysis of Linguistic Signals from Routine Primary Care Encounters

Depression is underdiagnosed in primary care, yet timely identification remains critical. Recorded clinical encounters, increasingly common with digital scribing technologies, present an opportunity to detect depression from naturalistic dialogue. We investigated automated depression detection from 1,108 audio-recorded primary care encounters in the Establishing Focus study, with depression defined by PHQ-9 (n=253 depressed, n=855 non-depressed). We compared three supervised approaches, Sentence-BERT + Logistic Regression (LR), LIWC+LR and ModernBERT, against a zero-shot GPT-OSS. GPT-OSS achieved the strongest performance (AUPRC=0.510, AUROC=0.774), with LIWC+LR competitive among supervised models (AUPRC=0.500, AUROC=0.742). Combined dyadic transcripts outperformed single-speaker configurations, with providers linguistically mirroring patients in depression encounters, an additive signal not captured by either speaker alone. Meaningful detection is achievable from the first 128 patient tokens (AUPRC=0.356, AUROC=0.675), supporting in-the-moment clinical decision support. These findings argue for passively collected clinical audio as a low-burden complement to existing screening workflows.
Mar 11, 2026

HeartAgent: An Autonomous Agent System for Explainable Differential Diagnosis in Cardiology

Heart diseases remain a leading cause of morbidity and mortality worldwide, necessitating accurate and trustworthy differential diagnosis. However, existing artificial intelligence-based diagnostic methods are often limited by insufficient cardiology knowledge, inadequate support for complex reasoning, and poor interpretability. Here we present HeartAgent, a cardiology-specific agent system designed to support a reliable and explainable differential diagnosis. HeartAgent integrates customized tools and curated data resources and orchestrates multiple specialized sub-agents to perform complex reasoning while generating transparent reasoning trajectories and verifiable supporting references. Evaluated on the MIMIC dataset and a private electronic health records cohort, HeartAgent achieved over 36% and 20% improvements over established comparative methods, in top-3 diagnostic accuracy, respectively. Additionally, clinicians assisted by HeartAgent demonstrated gains of 26.9% in diagnostic accuracy and 22.7% in explanatory quality compared with unaided experts. These results demonstrate that HeartAgent provides reliable, explainable, and clinically actionable decision support for cardiovascular care.
Mar 11, 2026

Emulating Clinician Cognition via Self-Evolving Deep Clinical Research

Clinical diagnosis is a complex cognitive process, grounded in dynamic cue acquisition and continuous expertise accumulation. Yet most current artificial intelligence (AI) systems are misaligned with this reality, treating diagnosis as single-pass retrospective prediction while lacking auditable mechanisms for governed improvement. We developed DxEvolve, a self-evolving diagnostic agent that bridges these gaps through an interactive deep clinical research workflow. The framework autonomously requisitions examinations and continually externalizes clinical experience from increasing encounter exposure as diagnostic cognition primitives. On the MIMIC-CDM benchmark, DxEvolve improved diagnostic accuracy by 11.2% on average over backbone models and reached 90.4% on a reader-study subset, comparable to the clinician reference (88.8%). DxEvolve improved accuracy on an independent external cohort by 10.2% (categories covered by the source cohort) and 17.1% (uncovered categories) compared to the competitive method. By transforming experience into a governable learning asset, DxEvolve supports an accountable pathway for the continual evolution of clinical AI.
Mar 11, 2026

Human-AI Co-reasoning for Clinical Diagnosis with Evidence-Integrated Language Agent

We present PULSE, a medical reasoning agent that combines a domain-tuned large language model with scientific literature retrieval to support diagnostic decision-making in complex real-world cases. To evaluate its capabilities, we curated a benchmark of 82 authentic endocrinology case reports encompassing a broad spectrum of disease types and incidence levels. In controlled experiments, we compared PULSE's performance against physicians with varying levels of expertise-from residents to senior specialists-and examined how AI assistance influenced human diagnostic reasoning. PULSE attained expert-competitive accuracy, outperforming residents and junior specialists while matching senior specialist performance at both Top@1 and Top@4 thresholds. Unlike physicians, whose accuracy declined with disease rarity, PULSE maintained stable performance across incidence tiers. The agent also exhibited adaptive reasoning, increasing output length with case difficulty in a manner analogous to the longer deliberation observed among expert clinicians. When used collaboratively, PULSE enabled physicians to correct initial errors and broaden diagnostic hypotheses, but also introduced risks of automation bias. The study explores both serial and concurrent collaboration workflows, revealing that PULSE offers robust support across common and rare presentations. These findings underscore both the promise and the limitations of language model-based agents in clinical diagnosis, and offer a framework for evaluating their role in real-world decision-making.
Mar 10, 2026

From Days to Minutes: An Autonomous AI Agent Achieves Reliable Clinical Triage in Remote Patient Monitoring

Background: Remote patient monitoring (RPM) generates vast data, yet landmark trials (Tele-HF, BEAT-HF) failed because data volume overwhelmed clinical staff. While TIM-HF2 showed 24/7 physician-led monitoring reduces mortality by 30%, this model remains prohibitively expensive and unscalable. Methods: We developed Sentinel, an autonomous AI agent using Model Context Protocol (MCP) for contextual triage of RPM vitals via 21 clinical tools and multi-step reasoning. Evaluation included: (1) self-consistency (100 readings x 5 runs); (2) comparison against rule-based thresholds; and (3) validation against 6 clinicians (3 physicians, 3 NPs) using a connected matrix design. A leave-one-out (LOO) analysis compared the agent against individual clinicians; severe overtriage cases underwent independent physician adjudication. Results: Against a human majority-vote standard (N=467), the agent achieved 95.8% emergency sensitivity and 88.5% sensitivity for all actionable alerts (85.7% specificity). Four-level exact accuracy was 69.4% (quadratic-weighted kappa=0.778); 95.9% of classifications were within one severity level. In LOO analysis, the agent outperformed every clinician in emergency sensitivity (97.5% vs. 60.0% aggregate) and actionable sensitivity (90.9% vs. 69.5%). While disagreements skewed toward overtriage (22.5%), independent adjudication of severe gaps (>=2 levels) validated agent escalation in 88-94% of cases; consensus resolution validated 100%. The agent showed near-perfect self-consistency (kappa=0.850). Median cost was $0.34/triage. Conclusions: Sentinel triages RPM vitals with sensitivity exceeding individual clinicians. By automating systematic context synthesis, Sentinel addresses the core limitation of prior RPM trials, offering a scalable path toward the intensive monitoring shown to reduce mortality while maintaining a clinically defensible overtriage profile.
Mar 9, 2026

A prospective clinical feasibility study of a conversational diagnostic AI in an ambulatory primary care clinic

Large language model (LLM)-based AI systems have shown promise for patient-facing diagnostic and management conversations in simulated settings. Translating these systems into clinical practice requires assessment in real-world workflows with rigorous safety oversight. We report a prospective, single-arm feasibility study of an LLM-based conversational AI, the Articulate Medical Intelligence Explorer (AMIE), conducting clinical history taking and presentation of potential diagnoses for patients to discuss with their provider at urgent care appointments at a leading academic medical center. 100 adult patients completed an AMIE text-chat interaction up to 5 days before their appointment. We sought to assess the conversational safety and quality, patient and clinician experience, and clinical reasoning capabilities compared to primary care providers (PCPs). Human safety supervisors monitored all patient-AMIE interactions in real time and did not need to intervene to stop any consultations based on pre-defined criteria. Patients reported high satisfaction and their attitudes towards AI improved after interacting with AMIE (p < 0.001). PCPs found AMIE's output useful with a positive impact on preparedness. AMIE's differential diagnosis (DDx) included the final diagnosis, per chart review 8 weeks post-encounter, in 90% of cases, with 75% top-3 accuracy. Blinded assessment of AMIE and PCP DDx and management (Mx) plans suggested similar overall DDx and Mx plan quality, without significant differences for DDx (p = 0.6) and appropriateness and safety of Mx (p = 0.1 and 1.0, respectively). PCPs outperformed AMIE in the practicality (p = 0.003) and cost effectiveness (p = 0.004) of Mx. While further research is needed, this study demonstrates the initial feasibility, safety, and user acceptance of conversational AI in a real-world setting, representing crucial steps towards clinical translation.
Mar 9, 2026

CORE-Acu: Structured Reasoning Traces and Knowledge Graph Safety Verification for Acupuncture Clinical Decision Support

Large language models (LLMs) show significant potential for clinical decision support (CDS), yet their black-box nature -- characterized by untraceable reasoning and probabilistic hallucinations -- poses severe challenges in acupuncture, a field demanding rigorous interpretability and safety. To address this, we propose CORE-Acu, a neuro-symbolic framework for acupuncture clinical decision support that integrates Structured Chain-of-Thought (S-CoT) with knowledge graph (KG) safety verification. First, we construct the first acupuncture Structured Reasoning Trace dataset and a schema-constrained fine-tuning framework. By enforcing an explicit causal chain from pattern identification to treatment principles, treatment plans, and acupoint selection, we transform implicit Traditional Chinese Medicine (TCM) reasoning into interpretable generation constraints, mitigating the opacity of LLM-based CDS. Furthermore, we construct a TCM safety knowledge graph and establish a ``Generate--Verify--Revise'' closed-loop inference system based on a Symbolic Veto Mechanism, employing deterministic rules to intercept hallucinations and enforce hard safety boundaries. Finally, we introduce the Lexicon-Matched Entity-Reweighted Loss (LMERL), which corrects terminology drift caused by the frequency--importance mismatch in general optimization by adaptively amplifying gradient contributions of high-risk entities during fine-tuning. Experiments on 1,000 held-out cases demonstrate CORE-Acu's superior entity fidelity and reasoning quality. Crucially, CORE-Acu achieved 0/1,000 observed safety violations (95% CI: 0--0.37%), whereas GPT-4o exhibited an 8.5% violation rate under identical rules. These results establish CORE-Acu as a robust neuro-symbolic framework for acupuncture clinical decision support, guaranteeing both reasoning auditability and strict safety compliance.
Mar 9, 2026

Optimising antibiotic switching via forecasting of patient physiology

Timely transition from intravenous (IV) to oral antibiotic therapy shortens hospital stays, reduces catheter-related infections, and lowers healthcare costs, yet one in five patients in England remain on IV antibiotics despite meeting switching criteria. Clinical decision support systems can improve switching rates, but approaches that learn from historical decisions reproduce the delays and inconsistencies of routine practice. We propose using neural processes to model vital sign trajectories probabilistically, predicting switch-readiness by comparing forecasts against clinical guidelines rather than learning from past actions, and ranking patients to prioritise clinical review. The design yields interpretable outputs, adapts to updated guidelines without retraining, and preserves clinical judgement. Validated on MIMIC-IV (US intensive care, 6,333 encounters) and UCLH (a large urban academic UK hospital group, 10,584 encounters), the system selects 2.2-3.2×\times more relevant patients than random. Our results demonstrate that forecasting patient physiology offers a principled foundation for decision support in antibiotic stewardship.
Mar 6, 2026

Artificial Intelligence for Detecting Fetal Orofacial Clefts and Advancing Medical Education

Orofacial clefts are among the most common congenital craniofacial abnormalities, yet accurate prenatal detection remains challenging due to the scarcity of experienced specialists and the relative rarity of the condition. Early and reliable diagnosis is essential to enable timely clinical intervention and reduce associated morbidity. Here we show that an artificial intelligence system, trained on over 45,139 ultrasound images from 9,215 fetuses across 22 hospitals, can diagnose fetal orofacial clefts with sensitivity and specificity exceeding 93% and 95% respectively, matching the performance of senior radiologists and substantially outperforming junior radiologists. When used as a medical copilot, the system raises junior radiologists' sensitivity by more than 6%. Beyond direct diagnostic assistance, the system also accelerates the development of clinical expertise. A pilot study involving 24 radiologists and trainees demonstrated that the model can improve the expertise development for rare conditions. This dual-purpose approach offers a scalable solution for improving both diagnostic accuracy and specialist training in settings where experienced radiologists are scarce.
Mar 6, 2026

InfoGatherer: Principled Information Seeking via Evidence Retrieval and Strategic Questioning

LLMs are increasingly deployed in high-stakes domains such as medical triage and legal assistance, often as document-grounded QA systems in which a user provides a description, relevant sources are retrieved, and an LLM generates a prediction. In practice, initial user queries are often underspecified, and a single retrieval pass is insufficient for reliable decision-making, leading to incorrect and overly confident answers. While follow-up questioning can elicit missing information, existing methods typically depend on implicit, unstructured confidence signals from the LLM, making it difficult to determine what remains unknown, what information matters most, and when to stop asking questions. We propose InfoGatherer, a framework that gathers missing information from two complementary sources: retrieved domain documents and targeted follow-up questions to the user. InfoGatherer models uncertainty using Dempster-Shafer belief assignments over a structured evidential network, enabling principled fusion of incomplete and potentially contradictory evidence from both sources without prematurely collapsing to a definitive answer. Across legal and medical tasks, InfoGatherer outperforms strong baselines while requiring fewer turns. By grounding uncertainty in formal evidential theory rather than heuristic LLM signals, InfoGatherer moves towards trustworthy, interpretable decision support in domains where reliability is critical.
Mar 6, 2026

Computational Pathology in the Era of Emerging Foundation and Agentic AI -- International Expert Perspectives on Clinical Integration and Translational Readiness

Recent breakthroughs in artificial intelligence through foundation models and agents have accelerated the evolution of computational pathology. Demonstrated performance gains reported across academia in benchmarking datasets in predictive tasks such as diagnosis, prognosis, and treatment response have ignited substantial enthusiasm for clinical application. Despite this development momentum, real world adoption has lagged, as implementation faces economic, technical, and administrative challenges. Beyond existing discussions of technical architectures and comparative performance, this review considers how these emerging AI systems can be responsibly integrated into medical practice by connecting deployable clinical relevance with downstream analytical capabilities and their technical maturity, operational readiness, and economic and regulatory context. Drawing on perspectives from an international group, we provide a practical assessment of current capabilities and barriers to adoption in patient care settings.
Mar 5, 2026

An interpretable prototype parts-based neural network for medical tabular data

The ability to interpret machine learning model decisions is critical in such domains as healthcare, where trust in model predictions is as important as their accuracy. Inspired by the development of prototype parts-based deep neural networks in computer vision, we propose a new model for tabular data, specifically tailored to medical records, that requires discretization of diagnostic result norms. Unlike the original vision models that rely on the spatial structure, our method employs trainable patching over features describing a patient, to learn meaningful prototypical parts from structured data. These parts are represented as binary or discretized feature subsets. This allows the model to express prototypes in human-readable terms, enabling alignment with clinical language and case-based reasoning. Our proposed neural network is inherently interpretable and offers interpretable concept-based predictions by comparing the patient's description to learned prototypes in the latent space of the network. In experiments, we demonstrate that the model achieves classification performance competitive to widely used baseline models on medical benchmark datasets, while also offering transparency, bridging the gap between predictive performance and interpretability in clinical decision support.
Mar 5, 2026

MedCoRAG: Interpretable Hepatology Diagnosis via Hybrid Evidence Retrieval and Multispecialty Consensus

Diagnosing hepatic diseases accurately and interpretably is critical, yet it remains challenging in real-world clinical settings. Existing AI approaches for clinical diagnosis often lack transparency, structured reasoning, and deployability. Recent efforts have leveraged large language models (LLMs), retrieval-augmented generation (RAG), and multi-agent collaboration. However, these approaches typically retrieve evidence from a single source and fail to support iterative, role-specialized deliberation grounded in structured clinical data. To address this, we propose MedCoRAG (i.e., Medical Collaborative RAG), an end-to-end framework that generates diagnostic hypotheses from standardized abnormal findings and constructs a patient-specific evidence package by jointly retrieving and pruning UMLS knowledge graph paths and clinical guidelines. It then performs Multi-Agent Collaborative Reasoning: a Router Agent dynamically dispatches Specialist Agents based on case complexity; these agents iteratively reason over the evidence and trigger targeted re-retrievals when needed, while a Generalist Agent synthesizes all deliberations into a traceable consensus diagnosis that emulates multidisciplinary consultation. Experimental results on hepatic disease cases from MIMIC-IV show that MedCoRAG outperforms existing methods and closed-source models in both diagnostic performance and reasoning interpretability.
Mar 4, 2026

MIND: Unified Inquiry and Diagnosis RL with Criteria Grounded Clinical Supports for Psychiatric Consultation

Psychiatric consultation requires agents to elicit discriminative evidence, map uncertain narratives to diagnostic criteria, and decide when evidence suffices. Existing dialogue and retrieval-augmented systems condition policies on raw histories or appended passages, leaving observed evidence, missing checks, differentials, and support reliability entangled. We introduce MIND, a criteria-grounded evidence-state decision interface. At each turn, MIND constructs a typed state containing observed evidence, unresolved criterion checks, active differentials, criterion-linked supports, and reliability metadata. A training-split Psychiatric Reasoning Bank supplies gated supports, turning retrieval into state construction rather than prompt injection. The same state conditions action selection, process rewards, information-gain scoring, and trajectory rectification. Under EMR-grounded simulator protocols, MIND improves accuracy by 8.8 and 7.3 points over strong inference-only, RAG, and RL baselines, with gains transferring to public MDD-5k dialogues. Matched interventions attribute these gains to the shared state rather than prompt length, retrieval text, or formatting. MIND targets screening-level decision support, not autonomous diagnosis. Code is available at https://github.com/Lingxi-mental-health/MIND.Å
Feb 28, 2026

MED-COPILOT: A Medical Assistant Powered by GraphRAG and Similar Patient Case Retrieval

Clinical decision-making requires synthesizing heterogeneous evidence, including patient histories, clinical guidelines, and trajectories of comparable cases. While large language models (LLMs) offer strong reasoning capabilities, they remain prone to hallucinations and struggle to integrate long, structured medical documents. We present MED-COPILOT, an interactive clinical decision-support system designed for clinicians and medical trainees, which combines guideline-grounded GraphRAG retrieval with hybrid semantic-keyword similar-patient retrieval to support transparent and evidence-aware clinical reasoning. The system builds a structured knowledge graph from WHO and NICE guidelines, applies community-level summarization for efficient retrieval, and maintains a 36,000-case similar-patient database derived from SOAP-normalized MIMIC-IV notes and Synthea-generated records. We evaluate our framework on clinical note completion and medical question answering, and demonstrate that it consistently outperforms parametric LLM baselines and standard RAG, improving both generation fidelity and clinical reasoning accuracy. The full system is available at https://huggingface.co/spaces/Cryo3978/Med_GraphRAG , enabling users to inspect retrieved evidence, visualize token-level similarity contributions, and conduct guided follow-up analysis. Our results demonstrate a practical and interpretable approach to integrating structured guideline knowledge with patient-level analogical evidence for clinical LLMs.
Feb 27, 2026

Experience-Guided Self-Adaptive Cascaded Agents for Breast Cancer Screening and Diagnosis with Reduced Biopsy Referrals

We propose an experience-guided cascaded multi-agent framework for Breast Ultrasound Screening and Diagnosis, called BUSD-Agent, that aims to reduce diagnostic escalation and unnecessary biopsy referrals. Our framework models screening and diagnosis as a two-stage, selective decision-making process. A lightweight screening clinic' agent, restricted to classification models as tools, selectively filters out benign and normal cases from further diagnostic escalation when malignancy risk and uncertainty are estimated as low. Cases that have higher risks are escalated to the diagnostic clinic' agent, which integrates richer perception and radiological description tools to make a secondary decision on biopsy referral. To improve agent performance, past records of pathology-confirmed outcomes along with image embeddings, model predictions, and historical agent actions are stored in a memory bank as structured decision trajectories. For each new case, BUSD-Agent retrieves similar past cases based on image, model response and confidence similarity to condition the agent's current decision policy. This enables retrieval-conditioned in-context adaptation that dynamically adjusts model trust and escalation thresholds from prior experiences without parameter updates. Evaluation across 10 breast ultrasound datasets shows that the proposed experience-guided workflow reduces diagnostic escalation in BUSD-Agent from 84.95% to 58.72% and overall biopsy referrals from 59.50% to 37.08%, compared to the same architecture without trajectory conditioning, while improving average screening specificity by 68.48% and diagnostic specificity by 6.33%.
Feb 26, 2026

Modeling Expert AI Diagnostic Alignment via Immutable Inference Snapshots

Human-in-the-loop validation is essential in safety-critical clinical AI, yet the transition between initial model inference and expert correction is rarely analyzed as a structured signal. We introduce a diagnostic alignment framework in which the AI-generated image based report is preserved as an immutable inference state and systematically compared with the physician-validated outcome. The inference pipeline integrates a vision-enabled large language model, BERT- based medical entity extraction, and a Sequential Language Model Inference (SLMI) step to enforce domain-consistent refinement prior to expert review. Evaluation on 21 dermatological cases (21 complete AI physician pairs) em- ployed a four-level concordance framework comprising exact primary match rate (PMR), semantic similarity-adjusted rate (AMR), cross-category alignment, and Comprehensive Concordance Rate (CCR). Exact agreement reached 71.4% and remained unchanged under semantic similarity (t = 0.60), while structured cross-category and differential overlap analysis yielded 100% comprehensive concordance (95% CI: [83.9%, 100%]). No cases demonstrated complete diagnostic divergence. These findings show that binary lexical evaluation substantially un- derestimates clinically meaningful alignment. Modeling expert validation as a structured transformation enables signal-aware quantification of correction dynamics and supports traceable, human aligned evaluation of image based clinical decision support systems.
Feb 25, 2026

Enhancing Framingham Cardiovascular Risk Score Transparency through Logic-Based XAI

Cardiovascular disease (CVD) remains one of the leading global health challenges, accounting for more than 19 million deaths worldwide. To address this, several tools that aim to predict CVD risk and support clinical decision making have been developed. In particular, the Framingham Risk Score (FRS) is one of the most widely used and recommended worldwide. However, it does not explain why a patient was assigned to a particular risk category nor how it can be reduced. Due to this lack of transparency, we present a logical explainer for the FRS. Based on first-order logic and explainable artificial intelligence (XAI) fundaments, the explainer is capable of identifying a minimal set of patient attributes that are sufficient to explain a given risk classification. Our explainer also produces actionable scenarios that illustrate which modifiable variables would reduce a patient's risk category. We evaluated all possible input combinations of the FRS (over 22,000 samples) and tested them with our explainer, successfully identifying important risk factors and suggesting focused interventions for each case. The results may improve clinician trust and facilitate a wider implementation of CVD risk assessment by converting opaque scores into transparent and prescriptive insights, particularly in areas with restricted access to specialists.
Feb 24, 2026

A Governance and Evaluation Framework for Deterministic, Rule-Based Clinical Decision Support in Empiric Antibiotic Prescribing

Empiric antibiotic prescribing in high-risk clinical contexts often requires decision making under conditions of incomplete information, where inappropriate coverage or unjustified escalation may compromise safety and antimicrobial stewardship. While clinical decision-support systems have been proposed to assist in this process, many approaches lack explicit governance and evaluation mechanisms defining scope, abstention conditions, recommendation permissibility, and expected system behavior. This work specifies a governance and evaluation framework for deterministic clinical decision-support systems operating under explicitly constrained scope. Deterministic behavior is adopted to ensure that identical inputs yield identical outputs, supporting transparency, auditability, and conservative decision support in high-risk prescribing contexts. The framework treats governance as a first-class design component, separating clinical decision logic from rule-based mechanisms that determine whether a recommendation may be issued. Explicit abstention, deterministic stewardship constraints, and exclusion rules are formalized as core constructs. The framework defines an evaluation methodology utilizing a fixed set of synthetic, mechanism-driven clinical cases with predefined expected behavior. This validation process focuses on behavioral alignment with specified rules rather than clinical effectiveness, predictive accuracy, or outcome optimization. Within this protocol, abstention is treated as a correct and intended outcome when governance conditions are not satisfied. The proposed framework provides a reproducible approach for specifying, governing, and inspecting deterministic clinical decision-support systems in empiric antibiotic prescribing contexts where transparency, auditability, and conservative behavior are prioritized.
Feb 22, 2026

DoAtlas-1: A Causal Compilation Paradigm for Clinical AI

Medical foundation models generate narrative explanations but cannot quantify intervention effects, detect evidence conflicts, or validate literature claims, limiting clinical auditability. We propose causal compilation, a paradigm that transforms medical evidence from narrative text into executable code. The paradigm standardizes heterogeneous research evidence into structured estimand objects, each explicitly specifying intervention contrast, effect scale, time horizon, and target population, supporting six executable causal queries: do-calculus, counterfactual reasoning, temporal trajectories, heterogeneous effects, mechanistic decomposition, and joint interventions. We instantiate this paradigm in DoAtlas-1, compiling 1,445 effect kernels from 754 studies through effect standardization, conflict-aware graph construction, and real-world validation (Human Phenotype Project, 10,000 participants). The system achieves 98.5% canonicalization accuracy and 80.5% query executability. This paradigm shifts medical AI from text generation to executable, auditable, and verifiable causal reasoning.
Feb 20, 2026

NutriOrion: A Hierarchical Multi-Agent Framework for Personalized Nutrition Intervention Grounded in Clinical Guidelines

Personalized nutrition intervention for patients with multimorbidity is critical for improving health outcomes, yet remains challenging because it requires the simultaneous integration of heterogeneous clinical conditions, medications, and dietary guidelines. Single-agent large language models (LLMs) often suffer from context overload and attention dilution when processing such high-dimensional patient profiles. We introduce NutriOrion, a hierarchical multi-agent framework with a parallel-then-sequential reasoning topology. NutriOrion decomposes nutrition planning into specialized domain agents with isolated contexts to mitigate anchoring bias, followed by a conditional refinement stage. The framework includes a multi-objective prioritization algorithm to resolve conflicting dietary requirements and a safety constraint mechanism that injects pharmacological contraindications as hard negative constraints during synthesis, ensuring clinical validity by construction rather than post-hoc filtering. For clinical interoperability, NutriOrion maps synthesized insights into the ADIME standard and FHIR R4 resources. Evaluated on 330 stroke patients with multimorbidity, NutriOrion outperforms multiple baselines, including GPT-4.1 and alternative multi-agent architectures. It achieves a 12.1 percent drug-food interaction violation rate, demonstrates strong personalization with negative correlations (-0.26 to -0.35) between patient biomarkers and recommended risk nutrients, and yields clinically meaningful dietary improvements, including a 167 percent increase in fiber and a 27 percent increase in potassium, alongside reductions in sodium (9 percent) and sugars (12 percent).
Feb 19, 2026

Machine Learning Based Prediction of Surgical Outcomes in Chronic Rhinosinusitis from Clinical Data

Artificial intelligence (AI) has increasingly transformed medical prognostics by enabling rapid and accurate analysis across imaging and pathology. However, the investigation of machine learning predictions applied to prospectively collected, standardized data from observational clinical intervention trials remains underexplored, despite its potential to reduce costs and improve patient outcomes. Chronic rhinosinusitis (CRS), a persistent inflammatory disease of the paranasal sinuses lasting more than three months, imposes a substantial burden on quality of life (QoL) and societal cost. Although many patients respond to medical therapy, others with refractory symptoms often pursue surgical intervention. Surgical decision-making in CRS is complex, as it must weigh known procedural risks against uncertain individualized outcomes. In this study, we evaluated supervised machine learning models for predicting surgical benefit in CRS, using the Sino-Nasal Outcome Test-22 (SNOT-22) as the primary patient-reported outcome. Our prospectively collected cohort from an observational intervention trial comprised patients who all underwent surgery; we investigated whether models trained only on preoperative data could identify patients who might not have been recommended surgery prior to the procedure. Across multiple algorithms, including an ensemble approach, our best model achieved approximately 85% classification accuracy, providing accurate and interpretable predictions of surgical candidacy. Moreover, on a held-out set of 30 cases spanning mixed difficulty, our model achieved 80% accuracy, exceeding the average prediction accuracy of expert clinicians (75.6%), demonstrating its potential to augment clinical decision-making and support personalized CRS care.
Feb 18, 2026

End-user validation of BRIGHT with custom-developed graphical user interface applied to cervical cancer brachytherapy

Multi-objective optimisation using BRIGHT has proven insightful and effective in prostate cancer brachytherapy treatment planning. BRachytherapy via artificially Intelligent GOMEA-Heuristic based Treatment planning (BRIGHT) generates multiple treatment plans, each with a different trade-off between tumour coverage and organs-at-risk sparing. BRIGHT was recently extended to cervical cancer brachytherapy. In this study, we present a novel, custom-developed graphical user interface (GUI) that enables plan navigation, pairwise comparisons, dose distribution visualisation, and possibility for adjustments - essential for efficient clinical use of BRIGHT. End-user validation of BRIGHT with the dedicated GUI was conducted for cervical cancer brachytherapy by emulating clinical practice in ten previously treated patients. A multidisciplinary brachytherapy team used BRIGHT to create new treatment plans. GUI usability was assessed using the System Usability Scale (SUS). BRIGHT plan quality was compared to clinical practice via blinded one-on-one comparisons. The GUI offered helpful features for plan navigation and evaluation, giving users quick insight into whether planning aims are achievable and what treatment options are available. The overall SUS score was 83.3, indicating an 'excellent' system. BRIGHT outperformed clinical practice in five out of ten patients regarding the coverage-sparing trade-off and performed equally well in the remaining five. The BRIGHT plan was preferred over the clinical plan in eight out of ten patients, four of which showed clinically relevant differences. The clinical plan was preferred in two patients, neither with clinically relevant differences. In conclusion, BRIGHT, with its dedicated GUI, is a clinically viable and user-friendly tool for treatment planning in cervical cancer brachytherapy.
Feb 11, 2026

A Patient Simulation Framework for Risk Assessment of Conversational Healthcare AI: Evaluation of an Antidepressant Decision Aid

Objective: This study develops and validates a patient simulation framework that aligns with the National Institute of Standards and Technology AI Risk Management Framework MAP and MEASURE functions, providing an empirical basis for identifying and characterizing performance risks in conversational clinical AI across medical, linguistic, and behavioral patient variation. We applied the framework to a conversational decision aid for antidepressant selection in major depressive disorder. Methods: The simulator integrates three profile dimensions: (1) medical profiles constructed from All of Us electronic health records using risk-ratio gating; (2) linguistic profiles modeling a health literacy gradient and condition-specific communication; and (3) behavioral profiles representing cooperative, distracted, and adversarial engagement. We generated 500 simulated conversations and evaluated profile fidelity through human annotation and a large language model (LLM) judge, then assessed downstream effects on the AI Decision Aid's concept retrieval and antidepressant recommendations. Results: The patient simulator expressed medical concepts with high fidelity (96.6% accurate across 8,210 concepts), with human inter-annotator agreement of 0.73κκ and LLM-judge agreement against human annotators of 0.78κκ, both indicating substantial agreement. Behavioral profiles were reliably distinguished (0.93κκ, near perfect agreement), and linguistic profiles showed substantial agreement at the lower bound of the substantial range (0.61κκ), adequate to support profile-level analysis. The framework revealed monotonic degradation in AI Decision Aid performance across the health literacy gradient. Rank-1 concept retrieval increased from 47.6% for limited health literacy to 81.9% for proficient health literacy, with corresponding declines in antidepressant recommendation accuracy.
Feb 9, 2026

CoMMa: Contribution-Aware Medical Multi-Agents for Decentralized Oncology Decision Support

Recent multi-agent frameworks have shown promise for oncology decision support, yet most assume centralized data access and rely on prompt-based assignment, limiting their applicability in privacy-sensitive clinical settings. We propose Contribution-Aware Medical Multi-Agents (CoMMa), a decentralized LLM-agent framework where specialists operate on partitioned clinical data streams. Unlike prior approaches that share inputs across agents, CoMMa enforces data decentralization to include stronger role specialization and further enhances this via agent-specific finetuning. To enable reliable and interpretable coordination, we introduce a contribution-aware aggregation mechanism that replaces stochastic, narrative-based reasoning with deterministic embedding projections to approximate each agent's marginal utility. This yields explicit credit assignment over agents, providing a stable and interpretable decision pathway aligned with clinical requirements. We evaluate CoMMa on multiple oncology benchmarks, including real-world multidisciplinary tumor board datasets from large academic hospitals in North America and East Asia, as well as public datasets, demonstrating strong performance and generalization across heterogeneous clinical settings.
Dec 9, 2025

Towards Optimal Valve Prescription for Transcatheter Aortic Valve Replacement (TAVR) Surgery: A Machine Learning Approach

Transcatheter Aortic Valve Replacement (TAVR) has emerged as a prominent, minimally invasive treatment for patients with severe aortic stenosis, a life-threatening cardiovascular condition. Multiple transcatheter heart valves (THV) have been approved for use in TAVR, but current guidelines regarding valve type prescription remain a topic of ongoing debate within the medical community. We propose a data-driven clinical support tool to identify the optimal valve type with the objective of minimizing the risk of permanent pacemaker implantation (PPI), a predominant postoperative complication. We synthesize a novel dataset, combining U.S. and Greek patient populations, that integrates data from three distinct sources (patient demographics, computed tomography scans, echocardiograms) while harmonizing the different encoding processes specific to each country's record system. We propose leaf-level analysis to leverage the heterogeneity of the patient populations and avoid benchmarking against uncertain counterfactual risk estimates. The final prescriptive model shows a reduction in PPI rates of 26% and 16% compared to the current standard of care in our internal U.S. population and external, Greek validation set, respectively. To the best of our knowledge, this work represents the first unified, personalized prescription strategy for THV selection in TAVR.
Dec 8, 2025

CLARITY: Medical World Model for Guiding Treatment Decisions by Modeling Context-Aware Disease Trajectories in Latent Space

Clinical decision-making in oncology requires predicting dynamic disease evolution, a task current static AI predictors cannot perform. While world models (WMs) offer a paradigm for generative prediction, existing medical applications remain limited. Existing methods often rely on stochastic diffusion models, focusing on visual reconstruction rather than causal, physiological transitions. Furthermore, in medical domain, models like MeWM typically ignore patient-specific temporal and clinical contexts and lack a feedback mechanism to link predictions to treatment decisions. To address these gaps, we introduce CLARITY, a medical world model that forecasts disease evolution directly within a structured latent space. It explicitly integrates time intervals (temporal context) and patient-specific data (clinical context) to model treatment-conditioned progression as a smooth, interpretable trajectory, and thus generate physiologically faithful, individualized treatment plans. Finally, CLARITY introduces a novel prediction-to-decision framework, translating latent rollouts into transparent, actionable recommendations. CLARITY demonstrates state-of-the-art performance in treatment planning. On the MU-Glioma-Post dataset, our approach outperforms recent MeWM by 12%, and significantly surpasses all other medical-specific large language models.
Dec 6, 2025

JEEVHITAA -- An HCAI Ecosystem to Support Collective Care

Current mobile health platforms are predominantly individual-centric and lack the support for coordinated, auditable multi-actor workflows. However, in many settings worldwide, health decisions are enacted through multi-actor coordination rather than individual users. We present JEEVHITAA, a cross-platform mobile system enabling role-aware sharing and verifiable information flows within permissioned care circles. JEEVHITAA ingests platform and device data, builds layered profiles from sensors and tiered onboarding, and enforces fine-grained, time-bounded access control across care graphs. Data stays secure both within the application and the cloud. Integrated retrieval-augmented Large Language Models produce structured, role-targeted summaries and action plans, offer evidence-grounded verification with provenance and confidence scores, and support advanced insights on reports. We describe the architecture, connector abstractions, and security primitives, and report robustness evaluations using synthetic, ontology-driven data and findings from a feasibility study with real-life care circles across 9-14 weeks. We outline plans for larger multi-site evaluations focusing on operational alignment, longitudinal trust & literacy impact, and relational friction & efforts to sink into the daily infrastructure.